Great Places to Work LarsonAllen LarsonAllen
Spacer Spacer

line
Don’t Delay: Tamper-Resistant Prescription Pads Mandatory on April 1
line The adjusted effective date for implementing tamper-resistant prescription pads is fast approaching. On April 1, 2008 physicians and pharmacists will be required by law to either use electronic prescriptions or tamper-resistant prescription pads for Medicaid patients.

Many health care providers nearly missed the new law when it was passed last May because it was embedded in a huge budget bill: the U.S. Troop Readiness, Veterans’ Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007.

Although the original implementation date was postponed, it is doubtful further delays will be approved. Develop your plan against fraud and substance abuse now.

Phased implementation
Per the Centers for Medicare & Medicaid Services (CMS), on April 1, 2008 tamper-resistant prescription pads must have at least one of the following three characteristics below. By October 1, 2008, all three of the characteristics must be present.

  • One or more industry-recognized features designed to prevent unauthorized copying of a completed or blank prescription form
  • One or more industry-recognized features designed to prevent erasure or modification of information written on the prescription by the prescriber
  • One or more industry-recognized features designed to prevent counterfeit prescription forms

Exceptions
According to guidance issued by CMS, the tamper-resistant statute does not affect faxed, emailed, or phoned-in prescriptions or prescriptions filled on an emergency basis. In addition, it does not apply when the prescription is written by a managed care facility.

Consequences of noncompliance
Each state is responsible for enforcing this law. Noncompliance could result in:

  • Loss of reimbursement for Medicaid prescriptions
  • Denied prescriptions from pharmacies
  • Penalties
  • Action from law enforcement and licensing boards
  • Unsafe patients due to medical complications
  • Disgruntled patients
  • Damaged reputation and loss of market share due to negative publicity

Background
In response to protests from physicians and pharmacists requesting more time to comply, the original implementation date (October 1, 2007) for this law was delayed by the President in September 2007. Congress approved the provision for the delay as part of a broader relief bill that extends Medicaid’s transitional medical assistance and abstinence education programs through the end of the year.

For more information, read CMS’ letter containing guidance to the state Medicaid directors, or contact Curt Mayse, health care principal, at 314-336-3726 or cmayse@larsonallen.com.

 

LarsonAllen Health Care Group LarsonAllen
Spacer
Contact Us

Name:
Email:

line
line
line
Spacer Spacer
Spacer

line

mail Share this with a friend   


About us - Careers - Contact us - Media - EFFECT - Site map - Home

Disclaimer - Web site terms of use - Privacy policy - Copyright policy
© 2000-2008 LarsonAllen® LLP  Equal Opportunity/Affirmative Action Employer
This site is best viewed with 5.0+ browsers at a resolution of 1024 x 768. To download a more recent version of your browser, click below.
Internet Explorer   Firefox